Summer greeting

July 4, 2012

With the holidays right around the corner, we want to take this opportunity to wish you all a warm and pleasant summer.

So far, 2012 has proved to be yet another exciting year in the world of Uniferon - not least thanks to our entries on a variety of new markets and our continued consolidation on the world's most important pig farming markets.

We are genuinely proud of the fact that almost 600 million pigs are injected with quality iron from Pharmacosmos each year. And we dedicate this to the high and homogenous quality of the product, the transparency of the entire production process and most importantly the positive effect on the piglets.

More than ever, an optimum iron selection can make the difference in a competitive world, and pig farmers all over the world have realized the significant relation between iron and the performance of a highly prolific sow herd. We believe that the near future will bring about an even stronger focus on improved health, growth and best practice, and we are here to help pig farmers' businesses grow through this process.

At Pharmacosmos, we look forward to resume work after summer, and we hope you will enjoy your summer holiday - whether on the beach on in the pigsty.

About Uniferon

Uniferon is a modern improved iron hydrogenated dextran based on a natural formula, which is approved for global use:

Uniferon is manufactured without the use of any organic solvents or cyanide, thus, avoiding trace residues of these impurities. Pharmacosmos manufactures iron dextran of high quality and unique purity for customers worldwide. Uniferon is the only injectable iron brand for piglets approved in the EU, the US and Asia.

About Pharmacosmos

Headquartered in Denmark, Pharmacosmos is a family-owned, international healthcare company with more than 50 years of innovation and leadership in iron- and carbohydrate-based treatments and solutions for human and animal use.

A research-based company, its ongoing R&D programme focuses on improving the lives of patients with iron deficiency with or without anaemia. More than 1 billion people live with iron deficiency anaemia and it is the leading cause of death for an estimated 180,000 people every year. This makes it one of the largest global health challenges of our time.

Pharmacosmos has subsidiaries in the Nordics, the UK and the US and its products are marketed in more than 80 countries across the world. Its manufacturing facilities are approved, among others, by the Danish Medicines Agency and the US FDA.